Agile Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Agile Therapeutics

26/07/2021 22:01

* Agile Therapeutics Inc  AGRX.OQ  reported a quarterly adjusted
loss of 20 cents​​ per share for the quarter ended in June. The
mean expectation of five analysts for the quarter was for a loss
of 22 cents per share.
* Revenue was $1.19 million​;  analysts expected $1.13 million. 
* Agile Therapeutics Inc's reported EPS for the quarter was a
loss of 20 cents​.
* The mean earnings estimate of analysts had fallen by
about 24.1% in the last three months.​ 
* In the last 30 days two analysts negatively revised earnings
estimates 
* Agile Therapeutics Inc shares had fallen by 12.8% this
quarter and lost 59.6% so far this year.
* The company reported a quarterly loss of $17.64 million.
* Wall Street's median 12-month price target for Agile
Therapeutics Inc is $6.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated July 26 at 09:00 p.m.  ​All
figures in US dollars unless otherwise stated